A novel microtubule-associated protein-2 expressed in oligodendrocytes in multiple sclerosis lesions

Bridget Shafit-Zagardo, Yvonne Kress, Meng Liang Zhao, Sunhee C. Lee

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Elucidation of the mechanisms involved in the regeneration of oligodendrocytes and remyelination is a central issue in multiple sclerosis (MS) research. We recently identified a novel alternatively spliced, developmentally regulated oligodendrocyte-specific protein designated microtubule-associated protein-2 + 13 [microtubule-associated protein-2 expressing exon 13 (MAP-2 + 13)]. MAP-2 + 13 is expressed in human fetal oligodendrocytes during process extension and myelination but is minimally expressed in normal mature CNS. To test the hypothesis that MAP-2 + 13 is reexpressed in regenerating oligodendrocytes in MS lesions, we examined the brains of MS patients for the expression of this protein. By immunocytochemistry using a series of monoclonal antibodies specific for MAP- 2 + 13, we determined that MAP-2 + 13 expression was up-regulated in all 31 lesions from 10 different MS brains. MAP-2 + 13 was expressed in regenerating oligodendrocytes associated with demyelinated lesions, with the highest counts found in regions of extensive remyelination. By electron microscopy, MAP-2 + 13 was localized to oligodendrocytes engaged in remyelination, evident by their process extension and association with thinly myelinated (remyelinated) and demyelinated axons. These results suggest a hitherto unsuspected role for this microtubule-associated protein in oligodendrocyte function during development and myelin repair.

Original languageEnglish (US)
Pages (from-to)2531-2537
Number of pages7
JournalJournal of Neurochemistry
Volume73
Issue number6
DOIs
StatePublished - 1999

Fingerprint

Microtubule-Associated Proteins
Oligodendroglia
Multiple Sclerosis
Brain
Electron microscopy
Exons
Repair
Monoclonal Antibodies
Proteins
Myelin Sheath
Axons
Regeneration
Electron Microscopy
Immunohistochemistry
Research

Keywords

  • Demyelination
  • Microtubule-associated protein-2
  • Multiple sclerosis
  • Myelination
  • Remyelination

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

A novel microtubule-associated protein-2 expressed in oligodendrocytes in multiple sclerosis lesions. / Shafit-Zagardo, Bridget; Kress, Yvonne; Zhao, Meng Liang; Lee, Sunhee C.

In: Journal of Neurochemistry, Vol. 73, No. 6, 1999, p. 2531-2537.

Research output: Contribution to journalArticle

Shafit-Zagardo, Bridget ; Kress, Yvonne ; Zhao, Meng Liang ; Lee, Sunhee C. / A novel microtubule-associated protein-2 expressed in oligodendrocytes in multiple sclerosis lesions. In: Journal of Neurochemistry. 1999 ; Vol. 73, No. 6. pp. 2531-2537.
@article{83c1a03b04454c5c82280df3393f7168,
title = "A novel microtubule-associated protein-2 expressed in oligodendrocytes in multiple sclerosis lesions",
abstract = "Elucidation of the mechanisms involved in the regeneration of oligodendrocytes and remyelination is a central issue in multiple sclerosis (MS) research. We recently identified a novel alternatively spliced, developmentally regulated oligodendrocyte-specific protein designated microtubule-associated protein-2 + 13 [microtubule-associated protein-2 expressing exon 13 (MAP-2 + 13)]. MAP-2 + 13 is expressed in human fetal oligodendrocytes during process extension and myelination but is minimally expressed in normal mature CNS. To test the hypothesis that MAP-2 + 13 is reexpressed in regenerating oligodendrocytes in MS lesions, we examined the brains of MS patients for the expression of this protein. By immunocytochemistry using a series of monoclonal antibodies specific for MAP- 2 + 13, we determined that MAP-2 + 13 expression was up-regulated in all 31 lesions from 10 different MS brains. MAP-2 + 13 was expressed in regenerating oligodendrocytes associated with demyelinated lesions, with the highest counts found in regions of extensive remyelination. By electron microscopy, MAP-2 + 13 was localized to oligodendrocytes engaged in remyelination, evident by their process extension and association with thinly myelinated (remyelinated) and demyelinated axons. These results suggest a hitherto unsuspected role for this microtubule-associated protein in oligodendrocyte function during development and myelin repair.",
keywords = "Demyelination, Microtubule-associated protein-2, Multiple sclerosis, Myelination, Remyelination",
author = "Bridget Shafit-Zagardo and Yvonne Kress and Zhao, {Meng Liang} and Lee, {Sunhee C.}",
year = "1999",
doi = "10.1046/j.1471-4159.1999.0732531.x",
language = "English (US)",
volume = "73",
pages = "2531--2537",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - A novel microtubule-associated protein-2 expressed in oligodendrocytes in multiple sclerosis lesions

AU - Shafit-Zagardo, Bridget

AU - Kress, Yvonne

AU - Zhao, Meng Liang

AU - Lee, Sunhee C.

PY - 1999

Y1 - 1999

N2 - Elucidation of the mechanisms involved in the regeneration of oligodendrocytes and remyelination is a central issue in multiple sclerosis (MS) research. We recently identified a novel alternatively spliced, developmentally regulated oligodendrocyte-specific protein designated microtubule-associated protein-2 + 13 [microtubule-associated protein-2 expressing exon 13 (MAP-2 + 13)]. MAP-2 + 13 is expressed in human fetal oligodendrocytes during process extension and myelination but is minimally expressed in normal mature CNS. To test the hypothesis that MAP-2 + 13 is reexpressed in regenerating oligodendrocytes in MS lesions, we examined the brains of MS patients for the expression of this protein. By immunocytochemistry using a series of monoclonal antibodies specific for MAP- 2 + 13, we determined that MAP-2 + 13 expression was up-regulated in all 31 lesions from 10 different MS brains. MAP-2 + 13 was expressed in regenerating oligodendrocytes associated with demyelinated lesions, with the highest counts found in regions of extensive remyelination. By electron microscopy, MAP-2 + 13 was localized to oligodendrocytes engaged in remyelination, evident by their process extension and association with thinly myelinated (remyelinated) and demyelinated axons. These results suggest a hitherto unsuspected role for this microtubule-associated protein in oligodendrocyte function during development and myelin repair.

AB - Elucidation of the mechanisms involved in the regeneration of oligodendrocytes and remyelination is a central issue in multiple sclerosis (MS) research. We recently identified a novel alternatively spliced, developmentally regulated oligodendrocyte-specific protein designated microtubule-associated protein-2 + 13 [microtubule-associated protein-2 expressing exon 13 (MAP-2 + 13)]. MAP-2 + 13 is expressed in human fetal oligodendrocytes during process extension and myelination but is minimally expressed in normal mature CNS. To test the hypothesis that MAP-2 + 13 is reexpressed in regenerating oligodendrocytes in MS lesions, we examined the brains of MS patients for the expression of this protein. By immunocytochemistry using a series of monoclonal antibodies specific for MAP- 2 + 13, we determined that MAP-2 + 13 expression was up-regulated in all 31 lesions from 10 different MS brains. MAP-2 + 13 was expressed in regenerating oligodendrocytes associated with demyelinated lesions, with the highest counts found in regions of extensive remyelination. By electron microscopy, MAP-2 + 13 was localized to oligodendrocytes engaged in remyelination, evident by their process extension and association with thinly myelinated (remyelinated) and demyelinated axons. These results suggest a hitherto unsuspected role for this microtubule-associated protein in oligodendrocyte function during development and myelin repair.

KW - Demyelination

KW - Microtubule-associated protein-2

KW - Multiple sclerosis

KW - Myelination

KW - Remyelination

UR - http://www.scopus.com/inward/record.url?scp=0032727866&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032727866&partnerID=8YFLogxK

U2 - 10.1046/j.1471-4159.1999.0732531.x

DO - 10.1046/j.1471-4159.1999.0732531.x

M3 - Article

C2 - 10582615

AN - SCOPUS:0032727866

VL - 73

SP - 2531

EP - 2537

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 6

ER -